Susceptibility Test Plate, Antifungal

Home/Specialty/Microbiology/Susceptibility Test Plate, Antifungal

Susceptibility Test Plate, Antifungal

Main Filters

Susceptibility Test Plate, Antifungal

BIOMERIEUX , INC.
CATALOG #	QTY	PRICE	DESCRIPTION
VITEK® 2 AST-YS05	0	-	The VITEK 2 Fungal Susceptibility Card is intended for use with the VITEK 2 systems as an in vitro test to determine the susceptibility of clinically significant yeast to antifungal agents
VITEK® 2 AST-YS09	0	-	The VITEK 2 ® Yeast Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant yeast.

BIOMERIEUX SA
CATALOG #	QTY	PRICE	DESCRIPTION
Etest® FLUCONAZOLE	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Fluconazole (FL)	0	-	ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative and Gram-positive aerobic bacteria and fastidious bacteria
ETEST® Fluconazole (FL)	0	-	Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Flucytosine (FC)	0	-	Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Flucytosine (FC)	0	-	Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions for MIC determination.
Etest® ITRACONAZOLE	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Itraconazole (IT)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.
ETEST® Voriconazole (VO)	0	-	Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.

REMEL, INC.
CATALOG #	QTY	PRICE	DESCRIPTION
Y3462	0	-
YO10	0	-	The Sensititre® YeastOne® Susceptibility system is a micro-version of the broth dilution susceptibility test. Various antifungal agents are serially diluted to concentrations bridging the range of the clinical interest in autoclaved diluent, which contains a colorimetric growth indicating compound. Each micro-dilution plate is individually packaged in foil. After inoculation, plates are sealed with an adhesive seal, incubated at 35°C for 24 hours and examined for growth.

TREK DIAGNOSTIC SYSTEMS LIMITED
CATALOG #	QTY	PRICE	DESCRIPTION
CMC1YOGV	0	-
YO2IVD	0	-
YO2IVD	0	-
YO3IVD	0	-
YO3IVD	0	-
YO4IVD	0	-

18 Results

Results Per Page

Catalog #

AvailableQty

Starting At

Name

Company Name

Description

YO3IVD

Sensititre

TREK DIAGNOSTIC SYSTEMS LIMITED

YO2IVD

Sensititre

TREK DIAGNOSTIC SYSTEMS LIMITED

ETEST® Fluconazole (FL)

BIOMERIEUX SA

ETEST® is a manual, quantitative technique for determination of antimicrobial susceptibility of non-fastidious Gram-negative and Gram-positive aerobic bacteria and fastidious bacteria

VITEK® 2 AST-YS09

BIOMERIEUX , INC.

The VITEK 2 ® Yeast Susceptibility Card is intended for use with the VITEK 2 to determine the susceptibility of clinically significant yeast.

ETEST® Voriconazole (VO)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Itraconazole (IT)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Flucytosine (FC)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Fluconazole (FL)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® ITRACONAZOLE

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.

ETEST® Flucytosine (FC)

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of antifungal. It provides a gradient of 15 doubling dilutions for MIC determination.

Etest® FLUCONAZOLE

BIOMERIEUX SA

Etest is a quantitative technique for determining susceptibility of clinically significant yeast. It provides a gradient of 15 doubling dilutions for MIC determination.

VITEK® 2 AST-YS05

BIOMERIEUX , INC.

The VITEK 2 Fungal Susceptibility Card is intended for use with the VITEK 2 systems as an in vitro test to determine the susceptibility of clinically significant yeast to antifungal agents

Y3462

REMEL, INC.

CMC1YOGV

Sensititre

TREK DIAGNOSTIC SYSTEMS LIMITED

YO4IVD

Sensititre

TREK DIAGNOSTIC SYSTEMS LIMITED

YO2IVD

Sensititre

TREK DIAGNOSTIC SYSTEMS LIMITED

YO3IVD

Sensititre

TREK DIAGNOSTIC SYSTEMS LIMITED

YO10

SENSITITRE YEASTONE SUSCEPTIBILITY PLATES

REMEL, INC.

The Sensititre® YeastOne® Susceptibility system is a micro-version of the broth dilution susceptibility test. Various antifungal agents are serially diluted to concentrations bridging the range of the clinical interest in autoclaved diluent, which contains a colorimetric growth indicating compound. Each micro-dilution plate is individually packaged in foil. After inoculation, plates are sealed with an adhesive seal, incubated at 35°C for 24 hours and examined for growth.